Time trend analysis of primary tumor resection for stage iv colorectal cancer less surgery, improved survival

JAMA Surgery

Volumn 150, Issue 3, 2015, Pages 245-251

  Hu, Chung Yuan ^a   Bailey, Christina E ^a   You, Y Nancy ^a   Skibber, John M ^a   Rodriguez Bigas, Miguel A ^a   Feig, Barry W ^a   Chang, George J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASIAN; BLACK PERSON; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; COLON TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; DIVORCED PERSON; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIED PERSON; OUTCOME ASSESSMENT; PACIFIC ISLANDER; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEPARATED PERSON; SEX DIFFERENCE; SINGLE MAN; SINGLE WOMAN; SURVIVAL RATE; TREND STUDY; UNITED STATES; WIDOWED PERSON; ADOLESCENT; CANCER STAGING; COLON RESECTION; COLONIC NEOPLASMS; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RECTAL NEOPLASMS; REGRESSION ANALYSIS; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLECTOMY; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECTAL NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84921898508     PISSN: 21686254     EISSN: 21686262     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.2253     Document Type: Article

References (27)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2): 104-117.
2. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2010. April 2013. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975-2010. Accessed February 20, 2014.
3. Cirocchi R, Trastulli S, Abraha I, et al. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev. 2012;8:CD008997.
4. Scheer MG, Sloots CE, van der Wilt GJ, Ruers TJ. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol. 2008;19(11):1829-1835.
5. Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol. 2003;14(suppl 2):ii13-ii16.
6. Scoggins CR,Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol. 1999;6(7):651-657.
7. Temple LK, Hsieh L,Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol. 2004;22(17): 3475-3484.
8. Saltz LB, Douillard JY, Pirotta N, et al. Irinotecan plus fluorouracil/leucovorin formetastatic colorectal cancer: a new survival standard. Oncologist. 2001;6(1):81-91.
9. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin formetastatic colorectal cancer. N Engl J Med. 2004;350(23):2335-2342.
10. Rothenberg ML, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouracilleucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol. 2003;21(11): 2059-2069.
11. Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008; 359(17):1757-1765.
12. Di Nicolantonio F, MartiniM, Molinari F, et al. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol. 2008;26(35):5705-5712.
13. McCahill LE, Yothers G, Sharif S, et al. Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectablemetastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. J Clin Oncol. 2012;30 (26):3223-3228.
14. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27(20): 3379-3384.
15. Benson AB III, Arnoletti JP, Bekaii-Saab T, et al; National Comprehensive Cancer Network. Colon cancer. J Natl Compr Canc Netw. 2011;9(11): 1238-1290.
16. Cook AD, Single R,McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol. 2005;12(8):637-645.
17. Surveillance, Epidemiology, and End Results (SEER) Program. SEER∗Stat Database: incidence-SEER 9 Regs Research Data, Nov 2011 Sub (1973-2010) -linked to county attributes-total U.S., 1969-2010 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission. http://www.seer.cancer.gov. Accessed May 1, 2013.
18. Kim HJ, Fay MP, Feuer EJ,Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3): 335-351.
19. Keeney S, Chang GJ, Linn S. Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E. J Biol Chem. 1993;268 (28):21293-21300.
20. Turunen MJ, Peltokallio P. Surgical results in 657 patients with colorectal cancer. Dis Colon Rectum. 1983;26(9):606-612.
21. Williams NS, Johnston D. The quality of life after rectal excision for low rectal cancer. Br J Surg. 1983; 70(8):460-462.
22. Rödel C, Grabenbauer GG, Papadopoulos T, HohenbergerW, Schmoll HJ, Sauer R. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol. 2003;21(16):3098-3104.
23. Venderbosch S, de Wilt JH, Teerenstra S, et al. Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol. 2011; 18(12):3252-3260.
24. Karoui M, Roudot-Thoraval F, Mesli F, et al. Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study [published correction appears in Dis Colon Rectum. 2011;54(10):1338]. Dis Colon Rectum. 2011; 54(8):930-938.
25. Rahbari NN, Lordick F, Fink C, et al; SYNCHRONOUS trial group. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectablemetastases (UICC stage IV): SYNCHRONOUS-a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer. 2012;12:142.
26. 't Lam-Boer J, Mol L, Verhoef C, et al. The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer-a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG). BMC Cancer. 2014;14:741.
27. Vargas GM, Sheffield KM, Parmar AD, et al. Trends in treatment and survival in older patients presenting with stage IV colorectal cancer. J Gastrointest Surg.2014;18(2):369-377.